Patent · US Active

Use of mirtazapine in the treatment of inflammatory disorders, autoimmune disease and PBC

US11510928B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2018
Grant dateNov 29, 2022
Priority date—
Expiry dateOct 6, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is described herein the use of mirtazapine in methods for the treatment of inflammatory disorders, autoimmune disease, and PBC.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.